The influence of antenatal exposure to phthalates on subsequent female reproductive development in adolescence: A pilot study

Reproduction

Volumn 147, Issue 4, 2014, Pages 379-390

  Hart, Roger ^a   Doherty, Dorota A ^a,b   Frederiksen, Hanne ^c   Keelan, Jeffrey A ^a,b   Hickey, Martha ^d   Sloboda, Deborah ^e   Pennell, Craig E ^a,b   Newnham, John P ^a,b   Skakkebaek, Niels E ^c   Main, Katharina M ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; INHIBIN B; MUELLERIAN INHIBITING FACTOR; PHTHALIC ACID DERIVATIVE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; BLOOD STORAGE; CONFERENCE PAPER; ECHOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE GENITAL SYSTEM; FOLLICULAR PHASE; GESTATIONAL AGE; HORMONE DETERMINATION; HUMAN; LIQUID CHROMATOGRAPHY; MATERNAL SERUM; MEASUREMENT; MENARCHE; ORGANOGENESIS; OVARY POLYCYSTIC DISEASE; PILOT STUDY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UTERUS WEIGHT; ADOLESCENT DEVELOPMENT; BLOOD; CHILD; COHORT ANALYSIS; DRUG EFFECTS; INFANT; PATHOPHYSIOLOGY; PREGNANCY; PRESCHOOL CHILD; PUBERTY; REPRODUCTION;

ADOLESCENT; ADOLESCENT DEVELOPMENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; PHTHALIC ACIDS; PILOT PROJECTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUBERTY; REPRODUCTION;

EID: 84896341785     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-13-0331     Document Type: Conference Paper

References (67)

1. Abbott DH, Barnett DK, Bruns CM & Dumesic DA 2005 Androgen excess fetal programming offemale reproduction: a developmental aetiology for polycystic ovary syndrome? Human Reproduction Update 11 357-374. (doi:10.1093/humupd/dmi013) (Pubitemid 40895465)
2. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J & Jacobs HS 1985 Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2 1375-1379. (doi:10.1016/S0140-6736 (85) 92552-8)
3. Adibi JJ, Whyatt RM, Hauser R, Bhat HK, Davis BJ, Calafat AM, Hoepner LA, Perera FP, Tang D & Williams PL 2010 Transcriptional biomarkers of steroidogenesis and trophoblast differentiation in the placenta in relation to prenatal phthalate exposure. Environmental Health Perspectives 118 291-296. (doi:10.1289/ehp. 0900788)
4. Andersson AM, Jorgensen N, Main KM, Toppari J, Rajpert-De Meyts E, Leffers H, Juul A, Jensen TK & Skakkebaek NE 2008 Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. International Journal of Andrology 31 74-80. (doi:10.1111/j.1365-2605. 2007.00853.x) (Pubitemid 351341375)
5. Auharek SA, De Franca LR, McKinnell C, Jobling MS, Scott HM & Sharpe RM 2010 Prenatal plus postnatal exposure to di (n-butyl) phthalate and/or flutamide markedly Definitions. Inreduces Sertoli cell number in the rat. Endocrinology and Metabolism Clinics of North America 15 2868-2875.
6. Balen AH, Laven JSE, Tan S-L & Dewailly D 2003 The ultrasound assessment of the polycystic ovary: International Consensus Definitions. In ASRM/ESHRE Consensus Meeting on Polycystic Ovary Syndrome, pp 1-25.
7. Boberg J, Christiansen S, Axelstad M, Kledal TS, Vinggaard AM, Dalgaard M, Nellemann C & Hass U 2011 Reproductive and behavioral effects of diisononyl phthtalate (DINP) in perinatally exposed rats. Reproductive Toxicology 31 200-209. (doi:10.1016/j.reprotox.2010. 11.001)
8. Christiansen S, Boberg J, Axelstad M, Dalgaard M, Vinggaard AM, Metzdorff SB & Hass U 2010 Low-dose perinatal exposure to di (2-ethylhexyl) phthalate induces anti-androgenic effects in male rats. Reproductive Toxicology 30 313-321. (doi:10.1016/j.reprotox.2010.04. 005)
9. Cole TJ, Bellizzi MC, Flegal KM & Dietz WH 2000 Establishing a standard definition for child overweight and obesity worldwide: international survey. British Medical Journal 320 (7244) 1240-1243. (Pubitemid 30240471)
10. Davis BJ, Maronpot RR & Heindel JJ 1994 Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicology and Applied Pharmacology 128 216-223. (doi:10.1006/taap. 1994.1200) (Pubitemid 24330842)
11. Desdoits-Lethimonier C, Albert O, Le Bizec B, Perdu E, Zalko D, Courant F, Lesne L, Guille F, Dejucq-Rainsford N & Jegou B 2012 Human testis steroidogenesis is inhibited by phthalates. Human Reproduction 27 1451-1459. (doi:10.1093/humrep/des069)
12. ESHRE/ASRM Rotterdam Consensus Meeting 2004a Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19 41-47. (doi:10.1093/humrep/deh098) (Pubitemid 38072004)
13. ESHRE/ASRM 2004b Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81 19-25.
14. Fagin D 2012 Toxicology: the learning curve. Nature 490 462-465. (doi:10.1038/490462a)
15. Frederiksen H, Skakkebaek NE & Andersson AM 2007 Metabolism of phthalates in humans. Molecular Nutrition & Food Research 51 899-911. (doi:10.1002/mnfr.200600243) (Pubitemid 47173700)
16. Frederiksen H, Jorgensen N & Andersson AM 2010 Correlations between phthalate metabolites in urine, serum, and seminal plasma from young Danish men determined by isotope dilution liquid chromatography tandem mass spectrometry. Journal of Analytical Toxicology 34 400-410. (doi:10.1093/jat/34.7.400)
17. Frederiksen H, Aksglaede L, Sorensen K, Skakkebaek NE, Juul A & Andersson AM 2011 Urinary excretion of phthalate metabolites in 129 healthy Danish children and adolescents: estimation of daily phthalate intake. Environmental Research 111 656-663. (doi:10.1016/j.envres. 2011.03.005)
18. Frederiksen H, Sorensen K, Mouritsen A, Aksglaede L, Hagen CP, Petersen JH, Skakkebaek NE, Andersson AM & Juul A 2012 High urinary phthalate concentration associated with delayed pubarche in girls. International Journal of Andrology 35 216-226. (doi:10.1111/j.1365-2605.2012.01260.x)
19. Hagen CP, Aksglaede L, Sorensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT et al. 2010 Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. Journal of Clinical Endocrinology and Metabolism 95 5003-5010. (doi:10.1210/jc.2010-0930)
20. Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, Petersen JH, Main KM & Juul A 2012 Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Human Reproduction 27 861-866. (doi:10.1093/humrep/ der435)
21. Handelsman DJ 2001 Estrogens and falling sperm counts. Reproduction, Fertility, and Development 13 317-324. (doi:10.1071/RD00103) (Pubitemid 33133350)
22. Hart R, Sloboda DM, Doherty DA, Norman RJ, Atkinson HC, Newnham JP, Dickinson JE & Hickey M 2009 Prenatal determinants of uterine volume and ovarian reserve in adolescence. Journal of Clinical Endocrinology and Metabolism 94 4931-4937. (doi:10.1210/jc.2009-1342)
23. Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M & Sloboda DM 2010a Serum anti-Müllerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertility and Sterility 94 1118-1121. (doi:10.1016/j.fertnstert.2009.11. 002)
24. Hart R, Sloboda D, Doherty D, Norman R, Atkinson H, Newnham J, Dickinson J & Hickey M 2010b Circulating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of anti-Müllerian hormone in adolescence: a prospective cohort study. Fertility and Sterility 94 1544-1547. (doi:10.1016/j.fertnstert.2009.12. 060)
25. Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP & Hart R 2009 The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. Journal of Clinical Endocrinology and Metabolism 94 3714-3720. (doi:10.1210/jc.2009-0544)
26. Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ & Hart R 2011 Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Human Reproduction 26 1469-1477.
27. Hines EP, Calafat AM, Silva MJ, Mendola P & Fenton SE 2009 Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environmental Health Perspectives 117 86-92. (doi:10.1289/ehp. 11610)
28. Hsu NY, Lee CC, Wang JY, Li YC, Chang HW, Chen CY, Bornehag CG, Wu PC, Sundell J & Su HJ 2012 Predicted risk of childhood allergy, asthma, and reported symptoms using measured phthalate exposure in dust and urine. Indoor Air 22 186-199. (doi:10.1111/j.1600-0668.2011. 00753.x)
29. Huang PC, Kuo PL, Chou YY, Lin SJ & Lee CC 2009 Association between prenatal exposure to phthalates and the health of newborns. Environment International 35 14-20. (doi:10.1016/j.envint.2008.05.012)
30. Janjua NR, Frederiksen H, Skakkebaek NE, Wulf HC & Andersson AM 2008 Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. International Journal of Andrology 31 118-130. (doi:10.1111/j.1365-2605.2007.00841.x)
31. Jobling MS, Hutchison GR, Van Den Driesche S & Sharpe RM 2011 Effects of di (n-butyl) phthalate exposure on foetal rat germ-cell number and differentiation: identification of age-specific windows of vulnerability. International Journal of Andrology 34 e386-e396. (doi:10.1111/j.1365-2605.2010. 01140.x)
32. Jurewicz J & Hanke W 2011 Exposure to phthalates: reproductive outcomes and children health. A review of epidemiological studies. International Journal of Occupational Medicine and Environmental Health 24 115-141. (doi:10.2478/s13382-011-0022-2)
33. Kato K, Silva MJ, Brock JW, Reidy JA, Malek NA, Hodge CC, Nakazawa H, Needham LL & Barr DB 2003 Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Journal of Analytical Toxicology 27 284-289. (doi:10.1093/jat/27.5.284) (Pubitemid 36877171)
34. Kortenkamp A 2007 Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environmental Health Perspectives 115(Suppl 1) 98-105. (doi:10.1289/ehp. 9357)
35. Kristensen D, Skalkam M, Audouze K, Lesne L, Desdoits-Lethimonier C, Frederiksen H, Brunak S, Skakkebaek N, Jegou B, Hansen J et al. 2011 Many putative endocrine disruptors inhibit prostaglandin synthesis. Environmental Health Perspectives 119 534-541. (doi:10.1289/ehp. 1002635)
36. Lethaby AE & Vollenhoven BJ 2008 An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best Practice & Research. Clinical Obstetrics & Gynaecology 22 307-331. (doi:10.1016/j. bpobgyn. 2007.07.010) (Pubitemid 351305698)
37. Lyche JL, Gutleb AC, Bergman A, Eriksen GS, Murk AJ, Ropstad E, Saunders M & Skaare JU 2009 Reproductive and developmental toxicity of phthalates. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 12 225-249. (doi:10.1080/10937400903094091)
38. Macdonald W, Newnham J, Gurrin L & Evans S 1996 Effect of frequent prenatal ultrasound on birthweight: follow up at 1 year of age. Western Australian Pregnancy Cohort (Raine) Working Group. Lancet 348 482. (doi:10.1016/S0140-6736 (05) 64587-4) (Pubitemid 26267900)
39. MacLeod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchinson GR, Drake AJ & Van Den Driesche S 2010 Androgen action in the masculinization programming window and development of male reproductive organs. International Journal of Andrology 33 279-287. (doi:10.1111/j.1365-2605.2009.01005.x)
40. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, Schmidt IM, Suomi AM, Virtanen HE, Petersen DV et al. 2006a Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environmental Health Perspectives 114 270-276. (doi:10.1289/ehp. 8075) (Pubitemid 43193651)
41. Main KM, Toppari J, Suomi AM, Kaleva M, Chellakooty M, Schmidt IM, Virtanen HE, Boisen KA, Kai CM, Damgaard IN et al. 2006b Larger testes and higher inhibin B levels in Finnish than in Danish newborn boys. Journal of Clinical Endocrinology and Metabolism 91 2732-2737. (doi:10.1210/jc.2005-2443) (Pubitemid 44024645)
42. Massart F, Parrino R, Seppia P, Federico G & Saggese G 2006 How do environmental estrogen disruptors induce precocious puberty? Minerva Pediatrica 58 247-254. (Pubitemid 44265116)
43. Meeker JD & Ferguson KK 2011 Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U. S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environmental Health Perspectives 119 1396-1402. (doi:10.1289/ehp. 1103582)
44. Van Meeuwen JA, Van Son O, Piersma AH, De Jong PC & Van Den Berg M 2008 Aromatase inhibiting and combined estrogenic effects of parabens and estrogenic effects of other additives in cosmetics. Toxicology and Applied Pharmacology 230 372-382. (doi:10.1016/j.taap. 2008.03.002)
45. Mitchell RT, Childs AJ, Anderson RA, Van Den Driesche S, Saunders PT, McKinnell C, Wallace WH, Kelnar CJ & Sharpe RM 2012 Do phthalates affect steroidogenesis by the human fetal testis? Exposure of human fetal testis xenografts to di-n-butyl phthalate Journal of Clinical Endocrinology and Metabolism 97 E341-E348. (doi:10.1210/jc.2011-2411)
46. Mose T, Mortensen GK, Hedegaard M & Knudsen LE 2007 Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reproductive Toxicology 23 83-91. (doi:10.1016/j.reprotox.2006.08.006) (Pubitemid 46027537)
47. Olsen L, Lampa E, Birkholz DA, Lind L & Lind PM 2012 Circulating levels of bisphenol A (BPA) and phthalates in an elderly population in Sweden, based on the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS). Ecotoxicology and Environmental Safety 75 242-248. (doi:10.1016/j. ecoenv. 2011.09.004)
48. Orsini LF, Venturoli S, Lorusso R, Pluchinotta V, Paradisi R & Bovicelli L 1985 Ultrasonic findings in polycystic ovarian disease. Fertility and Sterility 43 709-714. (Pubitemid 15062548)
49. Pierik FH, Burdorf A, Deddens JA, Juttmann RE & Weber RF 2004 Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environmental Health Perspectives 112 1570-1576. (doi:10.1289/ehp. 7243) (Pubitemid 39517453)
50. Reinsberg J, Wegener-Toper P, Van Der Ven K, Van Der Ven H & Klingmueller D 2009 Effect of mono-(2-ethylhexyl) phthalate on steroid production of human granulosa cells. Toxicology and Applied Pharmacology 239 116-123. (doi:10.1016/j.taap. 2009.05.022)
51. Sharpe RM & Skakkebaek NE 2008 Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertility and Sterility 89 e33-e38. (doi:10.1016/j.fertnstert.2007.12.026) (Pubitemid 351749385)
52. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL & Calafat AM 2004 Urinary levels of seven phthalate metabolites in the U. S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environmental Health Perspectives 112 331-338. (doi:10.1289/ehp. 6723) (Pubitemid 38351396)
53. Skakkebaek NE, Rajpert-De Meyts E & Main KM 2001 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction 16 972-978. (doi:10.1093/humrep/16.5. 972) (Pubitemid 32451837)
54. Skakkebaek NE, Rajpert-De Meyts E, Jørgensen N, Main KM, Leffers H & Andersson AM 2007 Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. International Journal of Andrology 30 198-204. (doi:10.1111/j.1365-2605.2007. 00776.x) (Pubitemid 47254416)
55. Sloboda DM, Hart R, Doherty DA, Pennell CE & Hickey M 2007 Age at menarche: Influences of prenatal and postnatal growth. Journal of Clinical Endocrinology and Metabolism 92 46-50. (doi:10.1210/jc. 2006-1378) (Pubitemid 46067507)
56. Sloboda DM, Hickey M & Hart R 2011 Reproduction in females: the role of the early life environment. Human Reproduction Update 17 210-227. (doi:10.1093/humupd/dmq048)
57. Suzuki Y, Yoshinaga J, Mizumoto Y, Serizawa S & Shiraishi H 2012 Foetal exposure to phthalate esters and anogenital distance in male newborns. International Journal of Andrology 35 236-244. (doi:10.1111/j.1365-2605.2011. 01190.x)
58. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, Mao CS, Redmon JB, Ternand CL, Sullivan S et al. 2005 Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives 113 1056-1061. (doi:10.1289/ehp. 8100) (Pubitemid 41149638)
59. Takai R, Hayashi S, Kiyokawa J, Iwata Y, Matsuo S, Suzuki M, Mizoguchi K, Chiba S & Deki T 2009 Collaborative work on evaluation of ovarian toxicity. 10) Two- or four-week repeated dose studies and fertility study of di-(2-ethylhexyl) phthalate (DEHP) in female rats. Journal of Toxicological Sciences 34(Suppl 1) SP111-SP119. (doi:10.2131/jts.34. S111)
60. Toppari J, Virtanen HE, Main KM & Skakkebaek NE 2010 Cryptorchidism and hypospadias as sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Research. Part A, Clinical and Molecular Teratology 88 910-919. (doi:10.1002/bdra.20707)
61. Uzumcu M, Kuhn PE, Marano JE, Armenti AE & Passantino L 2006 Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Müllerian hormone production in the rat ovary. Journal of Endocrinology 191 549-558. (doi:10.1677/joe.1.06592) (Pubitemid 46210281)
62. Wang W, Craig ZR, Basavarajappa MS, Gupta RK & Flaws JA 2012 Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway. Toxicology and Applied Pharmacology 258 288-295. (doi:10.1016/j.taap. 2011.11.008)
63. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB & Sharpe RM 2008 Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. Journal of Clinical Investigation 118 1479-1490. (doi:10.1172/JCI34241) (Pubitemid 351500441)
64. Wittassek M, Angerer J, Kolossa-Gehring M, Schafer SD, Klockenbusch W, Dobler L, Gunsel AK, Muller A & Wiesmuller GA 2009 Fetal exposure to phthalates - a pilot study. International Journal of Hygiene and Environmental Health 212 492-498. (doi:10.1016/j.ijheh.2009.04.001)
65. Wolff MS, Teitelbaum SL, Pinney SM, Windham G, Liao L, Biro F, Kushi LH, Erdmann C, Hiatt RA, Rybak ME et al. 2010 Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environmental Health Perspectives 118 1039-1046. (doi:10.1289/ehp. 0901690)
66. Yuan K, Zhao B, Li XW, Hu GX, Su Y, Chu Y, Akingbemi BT, Lian QQ & Ge RS 2012 Effects of phthalates on 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities in human and rat testes. Chemico-Biological Interactions 195 180-188. (doi:10.1016/j.cbi.2011.12.008)
67. Zawadzki J & Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovarian Syndrome, pp 374-388. Eds A Dunaif, JR Givens, F Haseltine, G R Merriam. Blackwell: Boston, MA, USA.